申请人:Prescient NeuroPharma Inc.
公开号:US06699909B1
公开(公告)日:2004-03-02
The present invention relates to therapeutically active novel aminoindanes of formula (I). Also provided is a method of preparing compounds of formula (I), and pharmaceutical compositions comprising the compounds. The novel compounds act as modulators of metabotropic glutamate receptors and, as such, are useful in treating diseases of the central nervous system related to the metabotropic glutamate receptor system.
本发明涉及具有式(I)的治疗活性新型氨基茚类化合物。还提供了一种制备式(I)化合物的方法,以及包含这些化合物的药物组合物。这些新型化合物作为代谢型谷氨酸受体的调节剂,因此在治疗与代谢型谷氨酸受体系统相关的中枢神经系统疾病方面具有用处。